For investors · Pre-seed round open
Building the next generation of gut–brain neurotechnology.
CortiAura is a UK neurotechnology company developing a non-invasive wearable that works with the gut–brain axis, founded by a gastroenterologist and a neuroscientist, and engineered to medical device safety standards from day one.
Request the investor deck
Why CortiAura
A clinician-led company, built to de‑risk.
Founded where the problem is
Led by an NHS gastroenterologist who sees the limits of today’s options in clinic every week.
Safety-first engineering
Built to ISO 13485, ISO 14971 and IEC 60601 from the first prototype with an experienced UK medical device partner.
Proprietary technology
Our approach is protected as we develop it. Technical detail is shared under NDA.
Flexible route to market
Designed to the highest standards so we can choose the right market entry with confidence.
Progress so far
What we have done
- Concept and scientific basis established
- Ranked in the top 15% of applications to the Cambridge NeuroWorks Blue Sky Proof-of-Concept Fund, powered by ARIA
- UK medical device engineering partner engaged; prototype development underway
- Early safety and feasibility study designed
- Regulatory and quality roadmap in place
- Founding Community of early adopters launched
This round
What it will fund
Prototype completion
From engineering design to working device
Safety and bench testing
Verification against recognised standards
Early study
Safety and feasibility with clinical collaborators
Protecting our IP
Building a defensible position as we grow
Investor deck
Request our deck.
Tell us a little about yourself and we will be in touch, usually within two working days, to arrange a short introductory call and share our investor materials.
Prefer email? Prashant@cortiaura.com
This page is for information only and is not an offer or invitation to buy shares. Investment opportunities are made available only to eligible investors through formal documentation. Investing in early-stage companies carries significant risk, including the loss of all capital invested.